2篇
您的检索式：作者名="Steven J.Ross"
|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Superior Vena Cava Occlusion as a Complication of Transvenous Cardiac Device Implantation:A Case Report and Brief Review显示文摘Superior vena cava(SVC)syndrome is a rare complication of transvenous cardiac device implantation,which may lead to delay of diagnosis when symptoms appear.A 68 year-old male with a dual chamber implantable defi brillator implanted 10 years prior presented to an emergency department with symptoms of facial swelling,frequent headaches,and early morning purple facial discoloration.At UF Health,he underwent computed tomographic(CT)scanning of the chest which was consistent with SVC syndrome,presumably a complication related to the prior implantation of his cardiac device.Despite the imaging fi ndings,venography remains the diagnostic modality of choice.Heparinization,catheter-based venography,and catheter thrombectomy with serial balloon angioplasty were performed for recanalization of the SVC,and the patient was ultimately discharged asymptomatic on apixaban for anticoagulation.However,symptoms recurred within two weeks.Ultimately,the patient underwent surgical right internal jugular vein to right atrial bypass with resolution of symptoms.A post-operative CT venogram was performed and the anastomosis was successful.Apparently an angiogram was not done at one year. | Steven J.Ross Sahil Prasada Hassan Ashraf David Wymer C.Richard Conti | 2019 | Cardiovascular Innovations and Applications2019，，B07： | 0 |
| 2 | Better Than You Think—Appropriate Use of Implantable Cardioverter-Defi brillators at a Single Academic Center:A Retrospective Review显示文摘Background:Implantable cardioverter-defi brillators(ICDs)can be life-saving devices,although they are expensive and may cause complications.In 2013,several professional societies published joint appropriate use criteria(AUC)assessing indications for ICD implantation.Data evaluating the clinical application of AUC are limited.Previous registry-based studies estimated that 22.5%of primary prevention ICD implantations were“non-evidence-based”implantations.On the basis of AUC,we aimed to determine the prevalence of“rarely appropriate”ICD implantation at our institution for comparison with previous estimates.Methods:We reviewed 286 patients who underwent ICD implantation between 2013 and 2016.Appropriateness of each ICD implantation was assessed by independent review and rated on the basis of AUC.Results:Of 286 ICD implantations,two independent reviewers found that 89.5%and 89.2%,respectively,were appropriate,5.6%and 7.3%may be appropriate,and 1.8%and 2.1%were rarely appropriate.No AUC indication was found for 3.5%and 3.4%of ICD implantations,respectively.Secondary prevention ICD implantations were more likely rarely appropriate(2.6%vs.1.2%and 3.6%vs.1.1%)or unrated(6.0%vs.1.2%and 2.7%vs.0.6%).The reviewers found 3.5%and 3.4%of ICD implantations,respectively,were non-evidence-based implantations.The difference in rates between reviewers was not statistically signifi cant.Conclusion:Compared with prior reports,our prevalence of rarely appropriate ICD implantation was very low.The high appropriate use rate could be explained by the fact that AUC are based on current clinical practice.The AUC could benefi t from additional secondary prevention indications.Most importantly,clinical judgement and individualized care should determine which patients receive ICDs irrespective of guidelines or criteria. | Nikhil H.Shah Steven J.Ross Steve A.Noutong Njapo Justin Merritt Andrew Kolarich Michael Kaufmann William M.Miles David E.Winchester Thomas A.Burkart Matthew McKillop | 2021 | Cardiovascular Innovations and Applications2021，，2： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员